Immune system modulation via antibody-mediated mechanisms

Immune system modulation via antibody-mediated mechanisms" refers to the broad set of processes by which antibodies influence and regulate immune responses. These include direct neutralization of pathogens and toxins, activation of the complement cascade leading to pathogen lysis, opsonization that enhances phagocytosis by immune cells, and triggering effector functions such as antibody-dependent cellular cytotoxicity (ADCC). The Fc region of antibodies interacts with Fc receptors on various cells—including macrophages, neutrophils, natural killer cells—and can modulate both pro-inflammatory and anti-inflammatory pathways. These processes are central in host defense against infections but also play roles in autoimmunity when dysregulated. Therapeutic strategies leveraging these mechanisms include monoclonal antibodies for cancer immunotherapy and autoimmune disease treatment. However, "immune system modulation via antibody-mediated mechanisms" is not a single molecular target but rather describes multiple pathways involving diverse molecules such as complement receptors (CR1/2), Fc gamma receptors (FcγR), and others[1][2][3][4]. As such, it cannot be classified as an individual therapeutic target like a receptor or enzyme. **Note:** This entry does not correspond to a single molecule/receptor but instead describes an entire class of biological processes/mechanisms. For structured data purposes requiring discrete targets—such as "CD20," "PD-L1," or "Fc gamma receptor IIb"—this entry should be flagged for review or refinement into more specific canonical forms.

Other names

Antibody-mediated immune modulationAntibody-mediated immune regulationHumoral immune response modulationAntibody effector mechanisms